# Satoshi Kobayashi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/satoshi-kobayashi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,187 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 20 |
| i10-index | 28 |
| Last Known Institution | Kyushu University |
| OpenAlex ID | https://openalex.org/A5007319655 |
| ORCID iD | 0000-0002-7760-0771 |
| Works | 158 |

## Researcher papers

- [Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial](https://scholariq.org/papers/neoadjuvant-oxaliplatin-and-capecitabine-and-bevacizumab-without-radiotherapy/)
- [Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).](https://scholariq.org/papers/trastuzumab-deruxtecan-t-dxd-ds-8201-in-patients-pts-with-her2-expressing/)
- [Dynamic CT of Hepatic Abscesses](https://scholariq.org/papers/dynamic-ct-of-hepatic-abscesses/)
- [Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study](https://scholariq.org/papers/early-results-of-multicenter-phase-ii-trial-of-perioperative-oxaliplatin-and/)
- [Cholecystectomy in octogenarians: be careful](https://scholariq.org/papers/cholecystectomy-in-octogenarians-be-careful/)
- [Efficient detection of somatic <i>UBA1</i> variants and clinical scoring system predicting patients with variants in VEXAS syndrome](https://scholariq.org/papers/efficient-detection-of-somatic-i-uba1-i-variants-and-clinical-scoring-system/)
- [Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score Matched Comparative Analysis](https://scholariq.org/papers/surgical-navigation-improves-renal-parenchyma-volume-preservation-in-robot/)
- [Histological Influence on Contrast-Enhanced CT of Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/histological-influence-on-contrast-enhanced-ct-of-pancreatic-ductal/)
- [Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy](https://scholariq.org/papers/efficacy-of-the-additional-use-of-ripasudil-a-rho-kinase-inhibitor-in-patients/)
- [One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy](https://scholariq.org/papers/one-year-efficacy-of-adjunctive-use-of-ripasudil-a-rho-kinase-inhibitor-in/)
- [Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy](https://scholariq.org/papers/assessment-of-surgical-skills-by-using-surgical-navigation-in-robot-assisted/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Researcher university

- [Kyushu University](https://scholariq.org/institutions/kyushu-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.